Centessa Pharmaceuticals plc (CNTA)

Centessa Pharmaceuticals Statistics

Total Valuation

CNTA has a market cap or net worth of $2.26 billion. The enterprise value is $1.83 billion.

Market Cap	2.26B
Enterprise Value	1.83B

Important Dates

The last earnings date was Tuesday, November 12, 2024, before market open.

Earnings Date	Nov 12, 2024
Ex-Dividend Date	n/a

Share Statistics

CNTA has 131.85 million shares outstanding. The number of shares has increased by 11.08% in one year.

Current Share Class	n/a
Shares Outstanding	131.85M
Shares Change (YoY)	+11.08%
Shares Change (QoQ)	+6.18%
Owned by Insiders (%)	1.49%
Owned by Institutions (%)	60.19%
Float	90.25M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	265.21
Forward PS	n/a
PB Ratio	4.53
P/TBV Ratio	4.53
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	266.85
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 21.52, with a Debt / Equity ratio of 0.17.

Current Ratio	21.52
Quick Ratio	21.15
Debt / Equity	0.17
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-15.88

Financial Efficiency

Return on equity (ROE) is -42.52% and return on invested capital (ROIC) is -21.80%.

Return on Equity (ROE)	-42.52%
Return on Assets (ROA)	-20.47%
Return on Capital (ROIC)	-21.80%
Revenue Per Employee	$90,171
Profits Per Employee	-$2.12M
Employee Count	76
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

In the past 12 months, CNTA has paid $2.94 million in taxes.

Income Tax	2.94M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +122.86% in the last 52 weeks. The beta is 1.53, so CNTA's price volatility has been higher than the market average.

Beta (5Y)	1.53
52-Week Price Change	+122.86%
50-Day Moving Average	16.61
200-Day Moving Average	12.53
Relative Strength Index (RSI)	50.89
Average Volume (20 Days)	705,714

Short Selling Information

Short Interest	3.35M
Short Previous Month	2.44M
Short % of Shares Out	3.12%
Short % of Float	n/a
Short Ratio (days to cover)	5.32

Income Statement

In the last 12 months, CNTA had revenue of $6.85 million and -$161.27 million in losses. Loss per share was -$1.52.

Revenue	6.85M
Gross Profit	6.85M
Operating Income	-161.65M
Pretax Income	-163.67M
Net Income	-161.27M
EBITDA	-161.30M
EBIT	-161.65M
Loss Per Share	-$1.52

Balance Sheet

The company has $518.45 million in cash and $84.72 million in debt, giving a net cash position of $433.73 million or $3.29 per share.

Cash & Cash Equivalents	518.45M
Total Debt	84.72M
Net Cash	433.73M
Net Cash Per Share	$3.29
Equity (Book Value)	499.14M
Book Value Per Share	3.79
Working Capital	541.96M

Cash Flow

In the last 12 months, operating cash flow was -$130.31 million and capital expenditures -$62,000, giving a free cash flow of -$130.37 million.

Operating Cash Flow	-130.31M
Capital Expenditures	-62,000
Free Cash Flow	-130.37M
FCF Per Share	-$0.99

Margins

Gross Margin	100.00%
Operating Margin	-2,358.86%
Pretax Margin	-2,310.33%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CNTA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-11.08%
Shareholder Yield	-11.08%
Earnings Yield	-7.13%
FCF Yield	-5.76%

Analyst Forecast

The average price target for CNTA is $23.71, which is 38.17% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$23.71
Price Target Difference	38.17%
Analyst Consensus	Strong Buy
Analyst Count	7
Revenue Growth Forecast (5Y)	103.99%
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

CNTA has an Altman Z-Score of 3.69 and a Piotroski F-Score of 2.

Altman Z-Score	3.69
Piotroski F-Score	2